Edwards Lifesciences Corporation EW
Set alert
92.01 USD -2.43 -2.57%
At close · Oct 30
92.01 0.00 0.00%
After hours · Oct 30, 6:00 PM ET
91.87 Day range 95.34
75.87 52-week range 95.18
- YTD
- +7.93%
- 1 year
- +10.22%
- Open
- 94.55
- Prev close
- 94.44
- Mkt cap
- 53.03B
- Vol
- 6.04M
- Avg vol
- 3.30M
- EPS
- 1.68
- P/E
- 54.77
- Div yield
- 0.00%
More statistics
- Low
- 91.87
- High
- 95.34
- Forward P/E
- 27.19
- Beta
- 0.86
- Short ratio
- 2.43
- Inst. own
- 95.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 88.10
- 200-d avg
- 85.38
- 1y target
- 101.87
5Y chart
Events in this range
- Jul 24, 2025Earnings: 0.67; estimate 0.624; surprise 7.37%
- Oct 30, 2025Earnings: 0.67; estimate 0.596; surprise 12.42%
- Feb 10, 2026Earnings: 0.58; estimate 0.618; surprise -6.15%
- Apr 23, 2026Earnings: 0.78; estimate 0.729; surprise 7%
- Jul 16, 2026Rating: Truist Securities · Hold → Hold
- Jul 23, 2026Earnings: 0.78; estimate 0.743; surprise 4.98%
- Jul 24, 2026Rating: Piper Sandler · Overweight → Overweight
- Jul 24, 2026Rating: JP Morgan · Overweight → Overweight
- Jul 24, 2026Rating: Leerink Partners · Market Perform → Outperform
- Sep 11, 2026Rating: BTIG · Buy → Buy
- Oct 7, 2026Rating: Barclays · — → Overweight
- Nov 4, 2026Earnings: —; estimate 0.737; surprise —%
Signals (100)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| MACD: Buy Signal | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 15, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Jan 13, 2025 | 1 year ago |
| SMA: Bullish | Dec 16, 2024 | 1 year ago |
| SMA: Bullish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Jul 22, 2024 | 2 years ago |
| RSI: Oversold | Jul 22, 2024 | 2 years ago |
| SMA: Bearish | Jul 15, 2024 | 2 years ago |
| SMA: Bullish | Jun 17, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | Jun 3, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 29, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 29, 2024 | 2 years ago |
| MACD: Buy Signal | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 27, 2023 | 2 years ago |
| RSI: Oversold | Oct 23, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| SMA: Bullish | Mar 13, 2023 | 3 years ago |
| SMA: Bullish | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bullish | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Dec 26, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 19, 2022 | 3 years ago |
| MACD: Sell Signal | Sep 19, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 5, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 18, 2022 | 4 years ago |
| SMA: Bullish | Jun 27, 2022 | 4 years ago |
| SMA: Bearish | Apr 25, 2022 | 4 years ago |
| SMA: Bullish | Mar 14, 2022 | 4 years ago |
| SMA: Bearish | Jan 10, 2022 | 4 years ago |
Key statistics
- Market cap
- 52.92B
- Enterprise value
- 50.99B
- Trailing P/E
- 54.71
- Forward P/E
- 27.19
- PEG ratio
- 1.98
- Price / sales
- 8.13
- Price / book
- 4.99
- EPS (TTM)
- 1.68
- Beta
- 0.86
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 15.43%
- Revenue (TTM)
- 6.51B
- Revenue growth
- 13.60%
- Free cash flow
- 1.23B
- Total cash
- 4.25B
- Total debt
- 704.40M
- Return on equity
- 9.18%
- Shares outstanding
- 575.80M
- Short % of float
- 1.84%
- 50-day average
- 88.10
- 200-day average
- 85.38
Analyst view
Consensus: buy
Buy
Price target (mean) 101.87 +10.7% upside
Now 92.01
- Target (low)
- 84.00
- Target (mean)
- 101.87
- Target (high)
- 117.00
Ratings (0m) 30 23 buy · 7 hold · 0 sell
- Strong buy5
- Buy18
- Hold7
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.73653.
Financials — quick view
EW Revenue — quarterly 1.74B
EW Net income — quarterly 241.90M
EW EPS — quarterly 0.42
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.737 | — | — | — |
| Jul 23, 2026 | Jun 30, 2026 | 0.743 | 0.78 | +0.04 | +4.98% |
| Apr 23, 2026 | Mar 31, 2026 | 0.729 | 0.78 | +0.05 | +7.00% |
| Feb 10, 2026 | Dec 31, 2025 | 0.618 | 0.58 | -0.04 | -6.15% |
| Oct 30, 2025 | Sep 30, 2025 | 0.596 | 0.67 | +0.07 | +12.42% |
| Jul 24, 2025 | Jun 30, 2025 | 0.624 | 0.67 | +0.05 | +7.37% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Barclays | init | — | Overweight |
| Sep 11, 2026 | BTIG | reit | Buy | Buy |
| Jul 24, 2026 | Leerink Partners | up | Market Perform | Outperform |
| Jul 24, 2026 | JP Morgan | main | Overweight | Overweight |
| Jul 24, 2026 | Piper Sandler | reit | Overweight | Overweight |
| Jul 16, 2026 | Truist Securities | main | Hold | Hold |
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- edwards.com
News
- Edwards' Q3 Earnings on the Horizon: What's in the Cards?
- Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key Metrics
- Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio Thrives
- $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
- 9 Health Care Stocks Whale Activity In Today’s Session
- FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death
- Reported Earlier, Edwards Lifesciences Tells Customers To Remove Four Lots Of Commander M Delivery Systems For SAPIEN M3; FDA Flags Potentially High-Risk Issue
- Barclays Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces Price Target of $110
- Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve
- Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Your note
Sign in to keep a note on EW — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOBO DONALD E JR | Officer | Sale | May 26, 2026 | 0 |
| CHOPRA DAVEEN | Officer | Sale | Aug 25, 2026 | 44,324 |
| GALLAHUE KIERAN T. | Director | Stock Award(Grant) | May 7, 2026 | 83,971 |
| LIPPIS DANIEL J | Officer | Sale | Oct 7, 2026 | 40,033 |
| LORANGER STEVEN R | Director | Stock Award(Grant) | May 7, 2026 | 84,369 |
| MISTRAS THEODORA | Chief Financial Officer | Stock Award(Grant) | Jul 8, 2026 | 99,920 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.21% | 58,789,433 | 5.40B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 37,615,952 | 3.46B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.59% | 26,411,402 | 2.43B | Jun 29, 2026 |
| State Street Corporation | 4.57% | 26,321,940 | 2.42B | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 3.96% | 22,783,175 | 2.09B | Jun 29, 2026 |
| Wellington Management Group, LLP | 2.92% | 16,827,967 | 1.55B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 18,279,615 | 1.68B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 14,919,502 | 1.37B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 12,476,018 | 1.15B | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.97% | 11,357,910 | 1.04B | Jul 30, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 7,683,257 | 706.17M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 7,474,400 | 686.97M | Aug 30, 2026 |